Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)
Clinical trial NCT01575925 · COMPLETED
Trial details
- NCT number
- NCT01575925
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2018-08-07
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.